Responses
Regular and young investigator award abstracts
Clinical trials in progress
337 Pembrolizumab in combination with xelox bevacizumab in patients with microsatellite stable (MSS) metastatic colorectal cancer and a high immune infiltrate: a proof of concept study. FFCD 1703 POCHI
Compose a Response to This Article
Other responses
No responses have been published for this article.
